ArticleAntibodies (Basel, Switzerland)2020

Anti gC1qR/p32/HABP1 Antibody Therapy Decreases Tumor Growth in an Orthotopic Murine Xenotransplant Model of Triple Negative Breast Cancer.

Ellinor I Peerschke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.